Document Detail


Characterization of antisense RNA-mediated inhibition of SIV replication.
MedLine Citation:
PMID:  8699163     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Antisense RNA-mediated inhibition of HIV showed mixed success in previous experiments. In order to elucidate the parameters influencing the efficacy of an antisense RNA approach, retroviral vectors encoding 4.5 kb, 3.5 kb, or 2.5 kb antisense RNA of the gag-pol region of SIV (simian immunodeficiency virus) were constructed and used to transduce a CD4-positive CEM174 cell line. The growth rate of transduced cells was measured, and results showed that antisense RNAs have no detrimental effect on cell growth. Similar levels of antisense RNA expression were observed in all transduced cells by Northern analysis. The transduced cells were challenged with uncloned SIVmac239 at a m.o.i. (multiplicity of infection) of 1.0, 0.1, or 0.01. At a m.o.i. of 1.0 or 0.1, no significant inhibition of viral replication was observed in any antisense construct transduced cells up to 9 days postinfection. At a lower m.o.i. (0.01), viral replication was effectively inhibited in 3.5 kb antisense transduced cells as compared to 4.5 kb and 2.5 kb antisense transduced cells at 15 days postinfection. These data suggest that the size of antisense RNA and the challenge dose play a significant role in achieving effective inhibition.
Authors:
F Y Tung; M H Tung
Related Documents :
21368833 - Scf(fbw7) regulates cellular apoptosis by targeting mcl1 for ubiquitylation and destruc...
15726423 - Rat enamel contains rp59: a new context for a protein from osteogenic and haematopoieti...
11027833 - Activation of mitogen-activated protein kinase through alpha5/beta1 integrin is require...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of medical virology     Volume:  48     ISSN:  0146-6615     ISO Abbreviation:  J. Med. Virol.     Publication Date:  1996 Apr 
Date Detail:
Created Date:  1996-09-05     Completed Date:  1996-09-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7705876     Medline TA:  J Med Virol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  321-5     Citation Subset:  IM; X    
Affiliation:
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, PA 15261, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / pharmacology*
Base Sequence
Blotting, Northern
Cell Line
Cell Transformation, Viral / genetics
DNA, Viral / analysis
Genetic Vectors / genetics
Molecular Sequence Data
Proviruses / genetics
RNA, Antisense / pharmacology*
RNA, Viral*
Retroviridae / genetics
Simian immunodeficiency virus / drug effects,  genetics,  physiology*
Viral Proteins / analysis
Virus Replication / drug effects*,  genetics
Grant Support
ID/Acronym/Agency:
AI31918/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/DNA, Viral; 0/RNA, Antisense; 0/RNA, Viral; 0/Viral Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the...
Next Document:  Isolation of varicella-zoster virus from vesicles in children with varicella.